Analysis of methionine synthase (rs1805087) gene polymorphism in autism patients in Northern Iran

• Autorzy: Haghin R. , Mashayekhi F. , Bidabadi E. , Salehi Z.
• Języki publikacji: EN

Abstrakty

EN

Autism is characterized by impairment in reciprocal communication and speech, repetitive behaviors, and social communication. The genetic and environmental factors play roles in the pathogenesis of autism. It was recently shown that the genes involved in the folate/homocysteine pathway may be risk factors for autistic children. One of the genes that may be the risk factor for autism is Methionine synthase (MTR). MTR is responsible for the regeneration of methionine from homocysteine. The aim of this study was to analyze the association of MTR A2756G gene polymorphism (rs1805087) and the risk of autism in a population in northern Iran. The prevalence of MTR A2756G polymorphism was determined in 108 children with autism and 130 controls in northern Iran. Genotypes and allele frequencies were determined in patients and controls by polymerase chain reaction‑restriction fragment length polymorphism (PCR‑RFLP). The prevalence of genotype frequencies of AA, AG and GG in autistic children were 57.41%, 22.22% and 20.37%, respectively, while in controls were 61.54%, 32.31% and 6.15%, respectively. There was significant difference between the MTR polymorphism distribution in control and patient groups. The prevalence of allele frequencies of A and G in autistic children were 0.69 and 0.31, respectively and in controls were 0.78 and 0.22, respectively (P=0.03). The MTR G allele conferred a 1.6‑fold increased risk to autism relative to the A allele (95% CI=1.06–2.41, P=0.02). The present study suggests that the G allele of MTR A2756G polymorphism is associated with an increased risk of autism.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2016
• Tom: 76
• Numer: 4
• Opis fizyczny: p.318-323,fig.,ref.

Twórcy

autor

Haghin R.

• Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran

autor

Mashayekhi F.

• Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran

autor

Bidabadi E.

• Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran

autor

Salehi Z.

• Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran

Bibliografia

• American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM‑IV‑TR). APA, Washington DC, USA. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T (2006) Prevalence of disorders of the autism spectrum in a  population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368: 210–215.
• Bandarian  V, Pattridge KA, Lennon BW, Huddler DP, Matthews RG, Ludwig  ML (2002) Domain alternation switches B(12)‑dependent methionine synthase to the activation conformation. Nat Struct Biol 9: 53–56.
• Centers for Disease Control and Prevention (2014) Prevalence of autism spectrum disorder among children aged 8  years ‑autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63: 1–21.
• Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862–4864.
• Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B (1997) Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 272: 3628–3634.
• Devlin B, Scherer SW (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 22: 229–237.
• Dorszewska J, Florczak J, Rozycka A, Kempisty B, Jaroszewska‑Kolecka J, Chojnacka K, Trzeciak WH, Kozubski W (2007) Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer’s and Parkinson’s diseases. Acta Neurobiol Exp (Wars) 67(2): 113–129.
• Evans JC, Huddler DP, Hilgers MT, Romanchuk G, Matthews RG, Ludwig ML (2004) Structures of the N‑ terminal modules imply large domain motions during catalysis by methionine synthase. Proc Natl Acad Sci U S A 101: 3729–3736.
• Födinger  M, Buchmayer H, Sunder‑Plassmann G (1999) Molecular genetics of homocysteine metabolism. Miner Electrolyte Metab 25: 269–278.
• Gillberg C (2010) The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. Res Dev Disabil 31: 1543–1551.
• Goode EL, Potter JD, Bigler J, Ulrich CM (2004) Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 13: 157–162.
• Guimarães JL, Ayrizono Mde  L, Coy CS, Lima CS (2011) Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma. Tumour Biol 32: 853–861.
• Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68: 1095–1102.
• Heijmans BT, Boer JM, Suchiman HE, Cornelisse CJ, Westendorp RG, Kromhout D, Feskens EJ, Slagboom PE (2003) A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63: 1249–1253.
• James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141: 947–956.
• James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70: 495–501.
• Jarrett JT, Huang S, Matthews RG (1998) Methionine synthase exists in two distinct conformations that differ in reactivity toward methyltetrahydrofolate, adenosylmethionine, and flavodoxin. Biochemistry 37: 5372–5382.
• Jensen KP (2005) Electronic structure of Cob(I)alamin: the story of an unusual nucleophile. J Phys Chem B 109: 10505–10512.
• Jiang‑Hua Q, De‑Chuang J, Zhen‑Duo  L, Shu‑de C, Zhenzhen  L (2014) Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancerrisk and interaction with folate, vitamin B6, and vitamin B12 intakes. Tumour Biol 35: 11895–11901.
• Kanner  L (1968) Autistic disturbances of affective contact. Acta Paedopsychiatr 35: 100–136.
• Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA (1998) Cloning and mapping of a  cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A 95: 3059–3064.
• Liu X, Solehdin F, Cohen IL, Gonzalez MG, Jenkins EC, Lewis ME, Holden JJ (2011) Population‑ and family‑based studies associate the MTHFR gene with idiopathic autism in simplex families. J Autism Dev Disord 41: 938–944.
• Lombardo MV, Ashwin E, Auyeung B, Chakrabarti B, Taylor K, Hackett G, Bullmore ET, Baron‑Cohen S (2012) Fetal testosterone influences sexually dimorphic gray matter in the human brain. J Neurosci 32: 674–680.
• Mashayekhi F1, Mizban N, Bidabadi E, Salehi Z (2016) The association of SHANK3 gene polymorphism and autism. Minerva Pediatr. epub ahead of print. McCaddon A, Regland B, Hudson P, Davies G (2002) Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 58: 1395–1399.
• Mohammad NS, Jain JM, Chintakindi KP, Singh RP, Naik U, Akella  RR (2009) Aberrations in folate metabolic pathway and altered susceptibility to autism. Psychiatr Genet 19: 171–176.
• Muratore CR, Hodgson NW, Trivedi MS, Abdolmaleky HM, Persico AM, Lintas C, De la Monte S, Deth RC (2013) Age‑dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS One 8: e56927.
• Rozycka A, Jagodzinski PP, Kozubski W, Lianeri M, Dorszewska J (2013) Homocysteine level and mechanisms of injury in Parkinson’s disease as related to MTHFR, MTR, and MTHFD1 genes polymorphisms and L‑dopa treatment. Curr Genomics 14: 534–542.
• Safari MR, Ghafouri‑Fard S, Noroozi R, Sayad A, Omrani MD, Komaki A, Eftekharian MM, Taheri  M (2017) FOXP3 gene variations and susceptibility to autism: A case‑control study. Gene 596: 119–122.
• Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Sconberg JL, Schmidt LC, Volk  HE, Tassone F (2015) Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study. Early Hum Dev 91: 483–489.
• Smalley SL, Asarnow RF, Spence MA (1988) Autism and genetics. A decade of research. Arch Gen Psychiatry 45: 953–961.
• Szelag E, Kowalska J, Galkowski T, Pöppel E (2004) Temporal processing deficits in high‑functioning children with autism. Br J Psychol 95: 269–282.
• Watkins D, Rosenblatt DS (1988) Genetic heterogeneity among patients with methylcobalamin deficiency. Definition of two complementationgroups, cblE and cblG. J Clin Invest 81: 1690–1694.
• Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu  JD (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10: 3441–3454
• Yu K, Zhang J, Zhang J, Dou C, Gu S, Xie Y, Mao Y, Ji C (2010) Methionine synthase A2756G polymorphism and cancer risk: a meta‑analysis. Eur J Hum Genet 18: 370–378.
• Zhu J, Wu  L, Kohlmeier  M, Ye F, Cai  W (2013) Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta‑analysis. Mol Med Rep 8: 919–927.